Expression and prognostic significance of pepsinogen C in gastric carcinoma

Annals of Surgical Oncology

Volumn 7, Issue 7, 2000, Pages 508-514

  Fernandez R ^a   Vizoso, F ^a   Rodriguez J C ^a   Merino, A M ^b   Gonzalez L O ^a   Quintela, I ^a   Andicoechea, A ^a   Truan, N ^a   Diez M C ^a  

^a HOSPITAL DE JOVE   (Spain)

^b HOSPITAL DE CABUEÑES   (Spain)

Author keywords

Gastric cancer; Pepsinogen A; Pepsinogen C; Prognosis

Indexed keywords

PEPSINOGEN; PEPSINOGEN II;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STOMACH CARCINOMA; TREATMENT OUTCOME;

EID: 0033855655     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0508-9     Document Type: Article

References (47)

1. Slow moving protease and the seven pepsinogens: Electrophoretic demonstration of the existence of eight proteolytic fraction in human gastric mucosa
2. Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence
3. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders
4. Relationship among serum pepsinogen I, serum pepsinogen II and gastric mucosal histology: A study in relatives of patient with pernicious anemia
5. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects
6. Chronic atrophic gastritis and serum pepsinogen levels
7. Serum pepsinogen I as a predictor of stomach cancer
8. Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies with data on peptic ulcer and gastric cancer
9. CA 50 determination in body fluids: Can we screen patients at risk for gastric cancer?
10. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population
11. Significance of serum markers pepsinogen I and II for chronic atrophic gastritis, peptic ulcer, and gastric cancer
12. Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer
13. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma
14. The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates
15. Serum pepsinogen as a new marker for gastric carcinoma among young adults
16. Helicobacter pylori infection, serum pepsinogen level and gastric cancer: A case-control study in Japan
17. Sensitivity and specificity of mass screening for gastric cancer using the measurement of serum pepsinogens
18. Accuracy of screening for gastric cancer using serum pepsinogen concentrations
19. Aspartic proteinases in gastric carcinomas
20. Pepsinogens in gastric carcinomas
21. Pepsinogens I and II in carcinoma of the stomach: An immunohistochemical study
22. Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases
23. Tissue and serum pepsinogen I and II in gastric cancer identified using immunohistochemistry and rapid ELISA
24. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal type carcinomas. An attempt at a histological classification
25. Isolation and characterisation of a pepsin C zymogen produced by human breast tissues
26. Production antisera with small doses of immunogen: Multiple intradermal injections
27. Nonparametric estimation from incomplete observations
28. Problems of convergence of maximum likelihood iterative procedures in multiparameter situations
29. Regression models and life tables
30. Pepsinogen C is a new prognostic marker in primary breast cancer
31. Expression of pepsinogen C in gynecomastias and male breast carcinomas
32. Ovarian mucinous tumors frequently express markers of gastric, intestinal, and pancreatobiliary epithelial cells
33. Cervical adenocarcinoma express markers common to gastric, intestinal, and pancreatobiliary epithelial cells
34. Expression of pepsinogen II with androgen and estrogen receptors in human prostate carcinoma
35. Methylation and expression of human pepsinogen genes in normal tissues and their alteration in stomach cancer
36. Elevation of tissue cathepsin B and L activities in gastric cancer
37. Cathepsin B and L activities in gastric cancer tissue: Correlation with histological findings
38. Immunohistochemical localization of cathepsins D and E in human gastric cancer: A possible correlation with local invasive and metastatic activities of carcinoma cells
39. Cathepsin D and E in normal, metaplastic, dysplastic, and carcinomatous gastric tissue: An immunohistochemical study
40. Human gastric cathepsin E gene. Multiple transcripts result from alternative polyadenylation of the primary transcripts of a single gene locus at Iq31-q32
41. Tumor-associated proteolysis and prognosis: New functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system
42. Prognosis relevance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in gastric cancer
43. Combined evaluation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression in gastric carcinoma
44. The role of proteases in cancer
45. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation